Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Blank

Showing results (81-90 of 106) with videos related to

Pageof 11
Sort By:
Arthritis Research & Therapy|October 28, 2019
Early treatment with ambrisentan of mildly elevated mean pulmonary arterial pressure associated with systemic sclerosis: a randomized, controlled, double-blind, parallel group study (EDITA study)Zixuan Pan, Alberto M Marra, Nicola Benjamin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 8, 2019
Reduced Right Ventricular Output Reserve in Patients With Systemic Sclerosis and Mildly Elevated Pulmonary Artery PressureChristian Nagel, Alberto M Marra, Nicola Benjamin, et al.
The Lancet. Rheumatology|March 31, 2025
First-line biological versus conventional synthetic disease-modifying antirheumatic drug therapy in adult-onset Still's disease: a multicentre, retrospective, propensity weighted cohort studyAnna Kernder, Tim Filla, Rhea Friedrich, et al.
Rheumatology (Oxford, England)|December 3, 2025
Fcγ-receptor-activation by circulating immune complexes in systemic autoimmune diseases and its reduction by CD19-CAR T-cell therapyMerle Freitag, Philipp Kolb, Valeria Falcone, et al.
Annals of the Rheumatic Diseases|October 7, 2016
Diagnostic criteria for cryopyrin-associated periodic syndrome (CAPS)Jasmin B Kuemmerle-Deschner, Seza Ozen, Pascal N Tyrrell, et al.
Rheumatology (Oxford, England)|October 3, 2017
International multi-centre study of pregnancy outcomes with interleukin-1 inhibitorsTaryn Youngstein, Patrycja Hoffmann, Ahmet Gül, et al.
Clinical and Experimental Rheumatology|October 7, 2020
Burden of illness in hereditary periodic fevers: a multinational observational patient diary studyJasmin B Kuemmerle-Deschner, Pierre Quartier, Isabelle Kone-Paut, et al.
RMD Open|February 15, 2024
Long-term safety and effectiveness of canakinumab in patients with monogenic autoinflammatory diseases: results from the interim analysis of the RELIANCE registryJasmin B Kuemmerle-Deschner, Tilmann Kallinich, Joerg Henes, et al.
Annals of the Rheumatic Diseases|December 22, 2023
Third-generation CD19.CAR-T cell-containing combination therapy in Scl70+ systemic sclerosisWolfgang Merkt, Merle Freitag, Maren Claus, et al.
Rheumatology (Oxford, England)|April 16, 2026
Treatment of systemic sclerosis-associated pulmonary hypertension with and without interstitial lung disease and its impact on survival: a large cohort study of the German network for systemic sclerosisMarc Schmalzing, Pia Moinzadeh, Jithmi Weliwitage, et al.
Pageof 11

Showing results (81-90 of 106) with videos related to

Sort By:
Pageof 11
Arthritis Research & Therapy|October 28, 2019
Early treatment with ambrisentan of mildly elevated mean pulmonary arterial pressure associated with systemic sclerosis: a randomized, controlled, double-blind, parallel group study (EDITA study)Zixuan Pan, Alberto M Marra, Nicola Benjamin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 8, 2019
Reduced Right Ventricular Output Reserve in Patients With Systemic Sclerosis and Mildly Elevated Pulmonary Artery PressureChristian Nagel, Alberto M Marra, Nicola Benjamin, et al.
The Lancet. Rheumatology|March 31, 2025
First-line biological versus conventional synthetic disease-modifying antirheumatic drug therapy in adult-onset Still's disease: a multicentre, retrospective, propensity weighted cohort studyAnna Kernder, Tim Filla, Rhea Friedrich, et al.
Rheumatology (Oxford, England)|December 3, 2025
Fcγ-receptor-activation by circulating immune complexes in systemic autoimmune diseases and its reduction by CD19-CAR T-cell therapyMerle Freitag, Philipp Kolb, Valeria Falcone, et al.
Annals of the Rheumatic Diseases|October 7, 2016
Diagnostic criteria for cryopyrin-associated periodic syndrome (CAPS)Jasmin B Kuemmerle-Deschner, Seza Ozen, Pascal N Tyrrell, et al.
Rheumatology (Oxford, England)|October 3, 2017
International multi-centre study of pregnancy outcomes with interleukin-1 inhibitorsTaryn Youngstein, Patrycja Hoffmann, Ahmet Gül, et al.
Clinical and Experimental Rheumatology|October 7, 2020
Burden of illness in hereditary periodic fevers: a multinational observational patient diary studyJasmin B Kuemmerle-Deschner, Pierre Quartier, Isabelle Kone-Paut, et al.
RMD Open|February 15, 2024
Long-term safety and effectiveness of canakinumab in patients with monogenic autoinflammatory diseases: results from the interim analysis of the RELIANCE registryJasmin B Kuemmerle-Deschner, Tilmann Kallinich, Joerg Henes, et al.
Annals of the Rheumatic Diseases|December 22, 2023
Third-generation CD19.CAR-T cell-containing combination therapy in Scl70+ systemic sclerosisWolfgang Merkt, Merle Freitag, Maren Claus, et al.
Rheumatology (Oxford, England)|April 16, 2026
Treatment of systemic sclerosis-associated pulmonary hypertension with and without interstitial lung disease and its impact on survival: a large cohort study of the German network for systemic sclerosisMarc Schmalzing, Pia Moinzadeh, Jithmi Weliwitage, et al.
Pageof 11